Zogenix to Participate in the BofA Securities 2020 Virtual Healthcare Conference

Rhea-AI Summary

Zogenix announced that Dr. Stephen J. Farr will participate in a fireside chat at the BofA Securities 2020 Virtual Healthcare Conference on May 13, 2020, at 3:00 PM Eastern Time. This event will be webcast live and archived for 90 days on Zogenix's Investor Relations website. The company is focused on developing therapies for rare diseases, including FINTEPLA® for Dravet and Lennox-Gastaut syndromes and MT1621 for TK2 deficiency.

EMERYVILLE, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, Ph.D., will participate in a fireside chat on Wednesday, May 13, 2020, at the BofA Securities 2020 Virtual Healthcare Conference.

100%; border-collapse:collapse !important;">

Zogenix Fireside Chat Details
Date:	Wednesday, May 13, 2020
Time:	3:00 PM Eastern Time
Webcast:	https://www.veracast.com/webcasts/bofa/healthcare2020/id67211238289.cfm

The fireside chat will be webcast live and archived for 90 days on Zogenix's Investor Relations website at https://zogenixinc.gcs-web.com.

About Zogenix
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.

CONTACTS:
Zogenix
Melinda Baker
Senior Director, Corporate Communications
+1 (510) 788-8732 | corpcomms@zogenix.com

Investors
Brian Ritchie
Managing Director, LifeSci Advisors LLC
+1 (212) 915-2578 | britchie@lifesciadvisors.com

FAQ

What is the date and time of Zogenix's fireside chat?

Zogenix's fireside chat is scheduled for May 13, 2020, at 3:00 PM Eastern Time.

Where can I watch the Zogenix fireside chat?

The Zogenix fireside chat can be watched live at https://www.veracast.com/webcasts/bofa/healthcare2020/id67211238289.cfm.

What are the main therapies Zogenix is developing?

Zogenix is developing FINTEPLA® for seizures associated with Dravet and Lennox-Gastaut syndromes and MT1621 for TK2 deficiency.

How long will the Zogenix fireside chat be archived?

The Zogenix fireside chat will be archived for 90 days on their Investor Relations website.

Who is presenting at the Zogenix fireside chat?

Dr. Stephen J. Farr will be presenting at the Zogenix fireside chat.